Previous studies have demonstrated that the derangement of cytokines drives colitis pathology and disease progression (Ranson et al., 2018; Waldner & Neurath, 2014), TNF‐α, IL‐1β, and IL‐6 are important pro‐inflammatory effectors that function in the context of intestinal inflammation. This evidence concerns the gene IL6 and colitis.